MEAGHER, M. F. Et Al. 2021. Cytoreductive nephrectomy in patients receiving TKI therapy versus immune checkpoint inhibitor therapy: Comparative outcome analysis of the REMARCC registry. European Association of Urology Congress - 2021 , (Çevrimiçi, Italy), 890-891.

MEAGHER, M. F., MINERVINI, A., MIR, M. C., REBEZ, G., AUTORINO, R., CAMPI, R., ... KRIEGMAIR, M. C.(2021). Cytoreductive nephrectomy in patients receiving TKI therapy versus immune checkpoint inhibitor therapy: Comparative outcome analysis of the REMARCC registry . European Association of Urology Congress - 2021 (pp.890-891). Çevrimiçi, Italy

MEAGHER, MARGARET Et Al. "Cytoreductive nephrectomy in patients receiving TKI therapy versus immune checkpoint inhibitor therapy: Comparative outcome analysis of the REMARCC registry," European Association of Urology Congress - 2021, Çevrimiçi, Italy, 2021

MEAGHER, MARGARET F. Et Al. "Cytoreductive nephrectomy in patients receiving TKI therapy versus immune checkpoint inhibitor therapy: Comparative outcome analysis of the REMARCC registry." European Association of Urology Congress - 2021 , Çevrimiçi, Italy, pp.890-891, 2021

MEAGHER, M. F. Et Al. (2021) . "Cytoreductive nephrectomy in patients receiving TKI therapy versus immune checkpoint inhibitor therapy: Comparative outcome analysis of the REMARCC registry." European Association of Urology Congress - 2021 , Çevrimiçi, Italy, pp.890-891.

@conferencepaper{conferencepaper, author={MARGARET F MEAGHER Et Al. }, title={Cytoreductive nephrectomy in patients receiving TKI therapy versus immune checkpoint inhibitor therapy: Comparative outcome analysis of the REMARCC registry}, congress name={European Association of Urology Congress - 2021}, city={Çevrimiçi}, country={Italy}, year={2021}, pages={890-891} }